M16-194 Skyrizi Ph3 PIP CD
ClinicalTrials.gov NCT05995353
Research payments
$9,707
Through program year 2024, $9,707 in research payments was reported against M16-194 Skyrizi Ph3 PIP CD, across 12 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT05995353
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $9,707 | 12 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jeffrey Bornstein Orlando, FL Named on 1 payment
- Ramalingam Arumugam Saint Paul, MN Named on 1 payment
- Xiaoyi Zhang Indianapolis, IN Named on 1 payment
- Travis Ayers Little Rock, AR Named on 1 payment
- Edwin Torres Reyes Arecibo, PR Named on 1 payment
- Edward Hoffenberg Aurora, CO Named on 1 payment
- Sabina Ali Oakland, CA Named on 1 payment
- Jess Kaplan Boston, MA Named on 1 payment
- Oren Koslowe Morristown, NJ Named on 1 payment
- Brad Pasternak Phoenix, AZ Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.